UNION CITY, Calif., April 28 /PRNewswire-FirstCall/ -- Abaxis, Inc. (NASDAQ:ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the fourth quarter of fiscal year 2008, ended March 31, 2008. The call will be at 4:15 p.m. ET on Thursday, May 1, 2008.
Participants can dial (877) 356-5706 or (706) 643-0580 to access the conference call, or can listen via a live Internet web cast, which can be found at http://www.abaxis.com/ under the Investor Relations tab. A replay of the call is available by visiting http://www.abaxis.com/ for the next 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 43094780, through May 4, 2008.
About Abaxis Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.
Contact: Clint Severson Lytham Partners, LLC
Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum
Abaxis, Inc. 602-889-9700
510-675-6500
DATASOURCE: Abaxis, Inc.
CONTACT: Clint Severson, Chief Executive Officer of Abaxis, Inc., +1-510-675-6500; or Joe Dorame, Joe Diaz & Robert Blum, all of Lytham Partners, LLC, +1-602-889-9700, for Abaxis, Inc.
Web site: http://www.abaxis.com/
|